head and neck cancer challenges & cetuximab trial updates
Published 5 years ago • 1.3K plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
2:54
extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer
-
2:53
positive results for palbociclib/cetuximab therapy in head and neck cancer
-
1:44
challenges for patients with head and neck cancer
-
1:23
evaluating options for hpv oropharyngeal cancer: cisplatin-rt vs. cetuximab-rt
-
4:57
cetuximab for oropharyngeal cancer: latest data from de-escalate
-
4:00
incorporating cetuximab in head and neck cancer treatment
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
1:52
esmo 2022 highlights in head and neck cancer
-
3:41
the challenges associated with the treatment of head and neck cancer
-
2:37
challenges of combining soc chemotherapy/radiotherapy and immunotherapy in head and neck cancer
-
2:28
palbociclib for platinum-resistant metastatic head and neck cancer
-
1:36
addition of an egfr/tgfβ inhibitor with pembrolizumab in head and neck cancer
-
8:56
cetuximab safety profile in head and neck cancer
-
1:15
dr. james melotek on cetuximab/chemotherapy combinations in head and neck cancer
-
1:22
the extreme regimen for head and neck cancer
-
1:12
dr. melotek on cetuximab added to chemotherapy and chemoradiation in head and neck cancer
-
1:31
dr. vokes on cetuximab for head and neck cancer
-
1:19
dr. ciccolini on dose levels of cetuximab in head and neck cancer
-
1:59
pembrolizumab in the treatment of head and neck cancer: is there more to the story?